Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Assets: 2013-2025

Historic Return on Assets for Ptc Therapeutics (PTCT) over the last 12 years, with Sep 2025 value amounting to 0.19%.

  • Ptc Therapeutics' Return on Assets rose 47.00% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 47.00%. This contributed to the annual value of -0.35% for FY2024, which is 5.00% up from last year.
  • Ptc Therapeutics' Return on Assets amounted to 0.19% in Q3 2025, which was up 33.70% from 0.14% recorded in Q2 2025.
  • Ptc Therapeutics' Return on Assets' 5-year high stood at 0.19% during Q3 2025, with a 5-year trough of -0.50% in Q3 2023.
  • For the 3-year period, Ptc Therapeutics' Return on Assets averaged around -0.23%, with its median value being -0.35% (2023).
  • Its Return on Assets has fluctuated over the past 5 years, first dropped by 18bps in 2023, then skyrocketed by 51bps in 2025.
  • Quarterly analysis of 5 years shows Ptc Therapeutics' Return on Assets stood at -0.27% in 2021, then declined by 8bps to -0.34% in 2022, then fell by 11bps to -0.45% in 2023, then climbed by 10bps to -0.35% in 2024, then spiked by 47bps to 0.19% in 2025.
  • Its last three reported values are 0.19% in Q3 2025, 0.14% for Q2 2025, and 0.15% during Q1 2025.